Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ev3 Expanding Vascular Presence Via $95 Mil. IntraTherapeutics Acquisition

This article was originally published in The Gray Sheet

Executive Summary

Private equity investor Warburg Pincus' ev3, Inc. unit is looking to build its peripheral vascular disease business through the purchase of Centerpulse subsidiary IntraTherapeutics for $95 mil. cash
Advertisement

Related Content

Terumo’s $170 Mil. Vascutek Purchase Builds Cardiovascular Offerings
Terumo’s $170 Mil. Vascutek Purchase Builds Cardiovascular Offerings
Centerpulse Divestitures Could Make Remaining Firm Attractive To Acquirers
Sulzer Medica IntraCoil Peripheral Stent Approved Despite Panel Reservations
Sulzer Medica Entering Peripheral Stent Market Via IntraTherapeutics
Sulzer Medica Entering Peripheral Stent Market Via IntraTherapeutics
Advertisement
UsernamePublicRestriction

Register

MT017113

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel